2017 FINAL AGENDA

TUESDAY, NOVEMBER 14, 2017

  • 8:00am Breakfast and Registration
  • 8:45am Morning Introduction (Salon II)

    Michael McCaughan
    Co-Founder
    Prevision Policy
     
  • 9:00am-10:00am: PDUFA VI, New Drug Approvals and Biosimilars (Salon II)

Anna Abram
Deputy Commissioner for Policy, Planning, Legislation & Analysis
FDA

Peter Stein
Deputy Director, Office of New Drugs, CDER
FDA

Sandra Milligan
SVP, Global Regulatory Affairs & Clinical Safety
Merck

Steven Galson
SVP, Global Regulatory Affairs & Safety
Amgen

Mathias Hukkelhoven
SVP, Global Regulatory, Safety & Biometrics
Bristol-Myers Squibb

Jeff Allen
CEO
Friends of Cancer Research

Kate Rawson (moderator)
Senior Editor
Prevision Policy

  • 10:00am-10:45am: Operationalizing Patient Input Into Approval Decisions (Salon II)

Rachel Sherman
Principal Deputy Commissioner
FDA

Wilson Bryan
Director, Office of Tissues & Advanced Therapies (CBER)
FDA

Caroline Kruse
Executive Director
Platelet Disorder Support Association

Cole Werble (moderator) 
Co-Founder
Prevision Policy

10:45am-11:00am: Break

  • 11:00am-12:00pm: FDA In 2020 (Salon II)

Richard Pazdur
Director, Oncology Center of Excellence
Food and Drug Administration (FDA)

Janet Woodcock
Director, Center for Drug Evaluation & Research
FDA

Peter Marks
Director, Center for Biologics Evaluation & Research
FDA

Ellen Sigal (moderator)
Founder and Chairperson
Friends of Cancer Research

  • 12:00pm-1:00pm: Lunch (Salon III)
  • 1:00pm-1:30pm: Second Year of Trump: Tax Reform, Government Shutdown, and Handicapping 2020 (Salon II)

    Chris Krueger
    Managing Director
    Cowen & Company

    Michael McCaughan (moderator)
    Co-Founder
    Prevision Policy
     
  • 1:30pm-2:30pm: State Health Reform Priorities for 2018 (Salon II)

    Jeff Myers
    CEO
    Medicaid Health Plans of America

    Kip Piper
    President
    Health Results Group

Tanisha Carino
VP, US Policy
GlaxoSmithKline

Lindsay Bealor Greenleaf (moderator)
Director
ADVI

2:30pm-2:45pm: Break

2:45:00pm-3:45pm: The Application of Value Data (Salon II)

Amy Bassano
Acting Director, Center for Medicare & Medicaid Innovation
CMS

Mike Ryan
SVP-US Value, Access, & Policy
Bristol-Myers Squibb

Mike Kolodziej
VP
ADVI

Barry Brooks
Chairman, P&T Committee
US Oncology

Lyn Fitzgerald
SVP-US & Global Development
National Comprehensive Cancer Network

Marc Samuels (moderator)
Founder and CEO
ADVI

  • 3:45pm-4:15pm: Pharmaceuticals & The ACA (Salon II)

Joe Grogan
Associate Director, Health Programs
Office of Management & Budget

Ramsey Baghdadi (moderator)
Co-Founder
Prevision Policy

  • 4:15pm-5pm: Healthcare 2020: Where Health Reform Is Headed For Biopharma (Salon II)

Tom Daschle
Founder & CEO, The Daschle Group
Former Senate Majority Leader

Mark McClellan
Director, Duke-Margolis Health Policy Center
Former CMS Administrator and FDA Commissioner

Ryan Hohman (moderator)
VP-Public Affairs
Friends of Cancer Research

Cocktail Reception 5:00pm-7:00pm (Quadrant Windows Room, Off the Main Lobby of the Ritz-Carlton)